440O Afatinib (A) vs gefitinib (G) in patients (pts) with...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

440O Afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7)

Park, K., Tan, E.H., Zhang, L., Hirsh, V., O'Byrne, K., Boyer, M., Yang, J.C-H., Mok, T., Lee, K.H., Lu, S., Shi, Y., Kim, S-W., Laskin, J., Kim, D-W., Laurie, S.A., Kölbeck, K., Fan, J., Dodd, N., Mä
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.004
Date:
December, 2016
File:
PDF, 64 KB
english, 2016
Conversion to is in progress
Conversion to is failed